These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A Factor I-Like Activity Associated with Chikungunya Virus Contributes to Its Resistance to the Human Complement System. Nag J, Mukesh RK, Suma SM, Kunnakkadan U, Kumar NA, Johnson JB. J Virol; 2020 Mar 17; 94(7):. PubMed ID: 31941783 [Abstract] [Full Text] [Related]
23. Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules. Tal-Singer R, Peng C, Ponce De Leon M, Abrams WR, Banfield BW, Tufaro F, Cohen GH, Eisenberg RJ. J Virol; 1995 Jul 17; 69(7):4471-83. PubMed ID: 7769707 [Abstract] [Full Text] [Related]
24. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus. Kostavasili I, Sahu A, Friedman HM, Eisenberg RJ, Cohen GH, Lambris JD. J Immunol; 1997 Feb 15; 158(4):1763-71. PubMed ID: 9029114 [Abstract] [Full Text] [Related]
25. Cloning and expression of the complement receptor glycoprotein C from Herpesvirus simiae (herpes B virus): protection from complement-mediated cell lysis. Huemer HP, Wechselberger C, Bennett AM, Falke D, Harrington L. J Gen Virol; 2003 May 15; 84(Pt 5):1091-1100. PubMed ID: 12692273 [Abstract] [Full Text] [Related]
31. Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM. Nicola AV, Ponce de Leon M, Xu R, Hou W, Whitbeck JC, Krummenacher C, Montgomery RI, Spear PG, Eisenberg RJ, Cohen GH. J Virol; 1998 May 15; 72(5):3595-601. PubMed ID: 9557640 [Abstract] [Full Text] [Related]
32. Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera. Luo Y, Xiong D, Li HH, Qiu SP, Lin CL, Chen Q, Huang CH, Yuan Q, Zhang J, Xia NS. Virol J; 2016 Mar 18; 13():44. PubMed ID: 26987753 [Abstract] [Full Text] [Related]
34. Molecular basis of the glycoprotein C-negative phenotypes of herpes simplex virus type 1 mutants selected with a virus-neutralizing monoclonal antibody. Homa FL, Purifoy DJ, Glorioso JC, Levine M. J Virol; 1986 May 18; 58(2):281-9. PubMed ID: 3009845 [Abstract] [Full Text] [Related]
35. Mapping of linear antigenic determinants on glycoprotein C of herpes simplex virus type 1 and type 2 recognized by human serum immunoglobulin G antibodies. Ackermann G, Ackermann F, Eggers HJ, Wieland U, Kühn JE. J Med Virol; 1998 Aug 18; 55(4):281-7. PubMed ID: 9661836 [Abstract] [Full Text] [Related]
36. Characterization and sequence analyses of antibody-selected antigenic variants of herpes simplex virus show a conformationally complex epitope on glycoprotein H. Gompels UA, Carss AL, Saxby C, Hancock DC, Forrester A, Minson AC. J Virol; 1991 May 18; 65(5):2393-401. PubMed ID: 1707982 [Abstract] [Full Text] [Related]
37. Interactions of a nonneutralizing IgM antibody and complement in parainfluenza virus neutralization. Vasantha S, Coelingh KL, Murphy BR, Dourmashkin RR, Hammer CH, Frank MM, Fries LF. Virology; 1988 Dec 18; 167(2):433-41. PubMed ID: 2849234 [Abstract] [Full Text] [Related]
38. Complement component C3b binds directly to purified glycoprotein C of herpes simplex virus types 1 and 2. Eisenberg RJ, Ponce de Leon M, Friedman HM, Fries LF, Frank MM, Hastings JC, Cohen GH. Microb Pathog; 1987 Dec 18; 3(6):423-35. PubMed ID: 2849025 [Abstract] [Full Text] [Related]
39. The herpes simplex virus 1 IgG fc receptor blocks antibody-mediated complement activation and antibody-dependent cellular cytotoxicity in vivo. Lubinski JM, Lazear HM, Awasthi S, Wang F, Friedman HM. J Virol; 2011 Apr 18; 85(7):3239-49. PubMed ID: 21228231 [Abstract] [Full Text] [Related]
40. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. Kuklin N, Daheshia M, Karem K, Manickan E, Rouse BT. J Virol; 1997 Apr 18; 71(4):3138-45. PubMed ID: 9060677 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]